Yumin Hu

4.8k total citations
76 papers, 3.8k citations indexed

About

Yumin Hu is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Yumin Hu has authored 76 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 24 papers in Cancer Research and 16 papers in Organic Chemistry. Recurrent topics in Yumin Hu's work include Cancer, Hypoxia, and Metabolism (20 papers), Histone Deacetylase Inhibitors Research (10 papers) and Catalytic C–H Functionalization Methods (8 papers). Yumin Hu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (20 papers), Histone Deacetylase Inhibitors Research (10 papers) and Catalytic C–H Functionalization Methods (8 papers). Yumin Hu collaborates with scholars based in China, United States and United Kingdom. Yumin Hu's co-authors include Peng Huang, Shijun Wen, Hélène Pelicano, Weiqin Lu, Wenhua Lu, Jérôme Alexandre, Li Feng, Michael J. Keating, Bingling Luo and Jing Yang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yumin Hu

76 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yumin Hu China	33	2.4k	1.2k	630	560	327	76	3.8k
Di Chen China	35	2.9k 1.2×	1.3k 1.1×	775 1.2×	378 0.7×	369 1.1×	96	4.4k
Saverio Tardito Italy	24	1.6k 0.7×	1.0k 0.9×	916 1.5×	413 0.7×	219 0.7×	37	3.1k
Stephen Gately United States	24	2.0k 0.8×	1.2k 1.0×	675 1.1×	373 0.7×	178 0.5×	40	3.5k
Shijun Wen China	36	2.0k 0.8×	628 0.5×	511 0.8×	1.2k 2.2×	166 0.5×	101	3.7k
Joseph M. Salvino United States	34	2.3k 1.0×	560 0.5×	691 1.1×	1.2k 2.2×	312 1.0×	106	3.7k
Lan‐Feng Dong Australia	37	2.5k 1.1×	1.2k 1.0×	479 0.8×	365 0.7×	249 0.8×	79	3.8k
Daniela Trisciuoglio Italy	35	2.9k 1.2×	951 0.8×	1.1k 1.7×	355 0.6×	496 1.5×	88	4.4k
Philip L. Lorenzi United States	35	2.5k 1.0×	1.2k 1.0×	679 1.1×	144 0.3×	286 0.9×	109	3.6k
Min Xiao China	24	1.6k 0.7×	601 0.5×	624 1.0×	499 0.9×	314 1.0×	73	3.0k
Chiara Gorrini Canada	17	3.1k 1.3×	772 0.7×	773 1.2×	263 0.5×	464 1.4×	23	4.6k

Countries citing papers authored by Yumin Hu

Since Specialization

Citations

This map shows the geographic impact of Yumin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Hu more than expected).

Fields of papers citing papers by Yumin Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Hu. The network helps show where Yumin Hu may publish in the future.

Co-authorship network of co-authors of Yumin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Hu. A scholar is included among the top collaborators of Yumin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Hu. Yumin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Rui, Wenhua Lu, Jing Yang, et al.. (2025). SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer. Cancer Letters. 616. 217586–217586. 3 indexed citations

Li, Jiangjiang, Jingyu Tian, Panpan Liu, et al.. (2024). Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature Communications. 15(1). 3445–3445. 16 indexed citations

Yao, Yao, Yanni Wang, Wanli Liu, et al.. (2024). An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature Communications. 15(1). 7136–7136. 25 indexed citations

Yao, Yao, Xueping Wang, Jian Guan, et al.. (2023). Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nature Communications. 14(1). 2339–2339. 26 indexed citations

Peng, Shaoyong, Yingjie Li, Meijin Huang, et al.. (2022). Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. International Journal of Biological Sciences. 18(5). 1912–1932. 48 indexed citations

Tian, Jingyu, Hui Zhang, Jing Yang, et al.. (2021). Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling. Molecular Metabolism. 48. 101203–101203. 29 indexed citations

Zhang, Wenli, Yajie Wang, Yanyan Liu, et al.. (2021). Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment. International Journal of Nanomedicine. Volume 16. 6141–6156. 30 indexed citations

Lu, Chenying, Shiji Fang, Qiaoyou Weng, et al.. (2020). Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Communication and Signaling. 18(1). 165–165. 1 indexed citations

Lu, Chenying, Shiji Fang, Qiaoyou Weng, et al.. (2020). Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Communication and Signaling. 18(1). 97–97. 50 indexed citations

10.

Liu, Xiaoxia, Yanyu Zhang, Wenhua Lu, et al.. (2020). Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo. Redox Biology. 36. 101652–101652. 32 indexed citations

11.

Glorieux, Christophe, Xiaojun Xia, Yumin Hu, et al.. (2020). Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling. Redox Biology. 38. 101780–101780. 60 indexed citations

12.

Li, Yan, Shuhai Lin, Lei Li, et al.. (2018). PDSS2 Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism. Cancer Research. 78(16). 4471–4481. 34 indexed citations

13.

Wen, Shijun, Panpan Liu, Yiqing Li, et al.. (2017). Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo. Cancer Letters. 413. 35–45. 33 indexed citations

14.

Luo, Bingling, Xiaobing Li, Wenhua Lu, et al.. (2017). Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells. Cell Death and Disease. 8(6). e2887–e2887. 100 indexed citations

15.

Zhang, Ruifang, Yuchuan Fu, Yi Lü, et al.. (2016). What is the optimal cutoff value of the axis-line-angle technique for evaluating trunk imbalance in coronal plane?. The Spine Journal. 17(2). 230–235. 3 indexed citations

16.

Liu, Kai‐Yan, Ping Chen, Panpan Liu, et al.. (2016). Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. International Journal of Oncology. 50(1). 252–262. 67 indexed citations

17.

Wang, Peng, et al.. (2015). Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase. Chinese Journal of Cancer. 34(3). 166–76. 19 indexed citations

18.

Li, Xiaobing, Wenhua Lu, Yumin Hu, et al.. (2013). Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate. International Journal of Oncology. 43(5). 1710–1718. 24 indexed citations

19.

Lu, Weiqin, Yumin Hu, Gang Chen, et al.. (2012). Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy. PLoS Biology. 10(5). e1001326–e1001326. 125 indexed citations

20.

Pelicano, Hélène, Weiqin Lu, Yan Zhou, et al.. (2009). Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism. Cancer Research. 69(6). 2375–2383. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact